Saudi Arabia SFDA registration ME0000000957SFDAA00231
CD7 (EP132)
Saudi Arabia·Chemicals·Cell Marque Corporation·Class IActiveProduct information
Rabbit Monoclonal Primary Antibody
Product use
is intended for laboratory use in the
detection of the CD7 glycoprotein in formalin-fixed, paraffin-embedded tissue stained in
qualitative immunohistochemistry (IHC) testing
Device classification
- Risk Class
- Class I
- Product Category
- Chemicals
- Product Type
- IVD
Registration information
- Registration ID
- ME0000000957SFDAA00231
- Authorization ID
- MDMA-1-2020-0954
- Status
- Active
- Expire Date
- April 10, 2026
Manufacturer
- Manufacturer Name
- Cell Marque Corporation
Model information
- Model ID(s)
- 107R-14 107R-15 107R-16 107R-17 107R-18
Product accessories
[]
About this record
Access comprehensive regulatory information for CD7 (EP132) in the Saudi Arabia medical device market through Pure Global AI's free database. This Class I device is registered with Saudi Arabia SFDA under registration number ME0000000957SFDAA00231 and manufactured by Cell Marque Corporation.
This page provides complete registration details including product category (Chemicals), manufacturer information, model details, and regulatory compliance data from the official Saudi Arabia SFDA medical device database. Pure Global AI offers free access to Saudi Arabia's complete medical device registry, helping global MedTech companies navigate SFDA regulations efficiently.
Free DatabasePowered by Pure Global AISFDA Official DataClass I